Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity.

Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity.

Item
http://www.wikidata.org/entity/Q38139529
β-Amyloid: the key peptide in the pathogenesis of Alzheimer's diseaseA semi-automated motion-tracking analysis of locomotion speed in the C. elegans transgenics overexpressing beta-amyloid in neurons.Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expressionIlex paraguariensis Extract Increases Lifespan and Protects Against the Toxic Effects Caused by Paraquat in Caenorhabditis elegansSpinosin, a C-Glucosylflavone, from Zizyphus jujuba var. spinosa Ameliorates Aβ1-42 Oligomer-Induced Memory Impairment in Mice.A Model for Improving the Learning Curves of Artificial Neural Networks.Caenorhabditis elegans as a model system for studying non-cell-autonomous mechanisms in protein-misfolding diseasesCaenorhabditis elegans: A Model System for Anti-Cancer Drug Discovery and Therapeutic Target Identification.A living model for obesity and aging research: Caenorhabditis elegans.Structure-dependent effects of amyloid-β on long-term memory in Lymnaea stagnalis.Otophylloside B Protects Against Aβ Toxicity in Caenorhabditis elegans Models of Alzheimer's Disease.Scalable electrophysiology in intact small animals with nanoscale suspended electrode arrays.Aspirin-Mediated Acetylation Protects Against Multiple Neurodegenerative Pathologies by Impeding Protein Aggregation.Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer's Disease.Coconut (Cocos nucifera) Ethanolic Leaf Extract Reduces Amyloid-β (1-42) Aggregation and Paralysis Prevalence in Transgenic Caenorhabditis elegans Independently of Free Radical Scavenging and Acetylcholinesterase Inhibition.
P2860

Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity.

Item
http://www.wikidata.org/entity/Q38139529
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Alzheimer's disease drug disco ...... loid peptide-induced toxicity.
@en
type
label
Alzheimer's disease drug disco ...... loid peptide-induced toxicity.
@en
prefLabel
Alzheimer's disease drug disco ...... loid peptide-induced toxicity.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Alzheimer's disease drug disco ...... loid peptide-induced toxicity.
@en
P2093
P2860
P304
P31
P356
10.1016/J.DDTEC.2012.02.002
P433
P478
P577
P698
P921
P932